Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Regulatory News (PRTC)

Share Price Information for PureTech (PRTC)

Share Price is delayed by 15 minutes
Get Live Data
131.40    1.40 (1.08%)
Bid:
131.20
Ask:
132.60
Spread: 1.40 (1.067%)
Market Cap: £319.85m
PRTC Live PriceLast checked at - London Stock Exchange

Intraday PureTech Share Chart

BTG

14 Aug 2019 17:30

RNS Number : 0959J
FTSE Russell
14 August 2019
 

 

 

 

 

 

Further to the FTSE Russell notice released on 12 August 2019 in relation to BTG (UK): Constituent Deletion, please note the FTSE 250 replacement.

 

All other details remain unchanged. Please see updated notice below:

 

BTG (UK): Constituent Deletion - UpdateChanges in FTSE UK Index Series

14 August 2019

Subject to court sanctioning the scheme of arrangement in relation to the cash acquisition of BTG (UK, constituent) by Bravo Bidco Ltd (non constituent), please see details of affected indexes and effective dates below:

 

 

 

BTG (UK, 0100159) will be deleted from the FTSE 250 Index.

 

Puretech Health (UK, BY2Z0H7) will be added to the FTSE 250 Index and removed from the FTSE SmallCap Index.

 

All changes effective from 19 August 2019.

 

Full details of index changes are available on the FTSE Russell website.

 

 

 

 

 

For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:

Australia

+1800 653 680

Hong Kong

+852 2164 3333

Japan

+81 3 4563 6346

London

+44 (0) 20 7866 1810

New York

+1866 551 0617

 

Alternatively please visit our website at www.ftserussell.com

Terms of Use | Copyright © 2019 FTSE Russell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FTSEZLFFKVFEBBL
Date   Source Headline
24th Jun 20217:00 amRNSPDMR DEALING - PURCHASE OF SHARES
23rd Jun 20211:28 pmRNSKaruna Announces KarXT Results in Healthy Elderly
16th Jun 202112:00 pmRNSPureTech Acquires Alivio and Oral IL-22 Candidate
2nd Jun 20217:00 amRNSPDMR Notification RSU Vesting
1st Jun 20217:00 amRNSTotal Voting Rights
27th May 20216:16 pmRNSResult of AGM
27th May 20212:50 pmRNSPureTech’s Gelesis Presents Plenity Data at AACE
26th May 20211:05 pmRNSPureTech’s Akili Secures $160M in Financing
25th May 202112:00 pmRNSPRTC Presents at Jefferies Healthcare Conference
12th May 202112:00 pmRNSPureTech Forms IPF Clinical Advisory Board
28th Apr 20214:08 pmRNSNew PureTech Research Published in Nature Journal
26th Apr 20211:05 pmRNSGelesis Appoints Procter & Gamble Veteran to BOD
15th Apr 20217:00 amRNSFinal Results
12th Apr 202112:00 pmRNSPRTC Presents Data for LYT-210 IO Program at AACR
7th Apr 202112:00 pmRNSPureTech to Present at Two Investor Conferences
7th Apr 202110:15 amRNSAkili Collab to Study Long COVID-Related Brain Fog
26th Mar 202112:02 pmRNSAkili Data Published in Nature Digital Medicine
24th Mar 20217:00 amRNSHolding(s) in Company
18th Mar 20217:00 amRNSDirectorate Change
15th Mar 20217:00 amRNSNotice of Results
3rd Mar 202112:00 pmRNSPRTC Presents at Barclays Healthcare Conference
2nd Mar 20211:01 pmRNSKaruna Prices Approximately $250M Public Offering
25th Feb 20212:00 pmRNSPRTC Publishes Lymphatic Targeting Study for Glyph
25th Feb 20217:00 amRNSKaruna data in New England Journal of Medicine
18th Feb 202112:00 pmRNSPRTC Presents at SVB Leerink Healthcare Conference
10th Feb 20217:05 amRNSVor Closes Over $200M Initial Public Offering
10th Feb 20217:00 amRNSPRTC Receives $118M from Founded Entity Shares
8th Feb 202112:00 pmRNSVedanta Adds Biotech Finance and IR Expert as CFO
5th Feb 202111:46 amRNSPureTech Founded Entity Vor Lists on Nasdaq
5th Feb 20217:00 amRNSHolding(s) in Company
1st Feb 20217:00 amRNSTotal Voting Rights
29th Jan 20217:00 amRNSPureTech Appoints Bharatt Chowrira to BOD
18th Jan 20217:00 amRNSVor Files IPO Registration Statement on Nasdaq
14th Jan 202112:05 pmRNSVor Announces FDA Acceptance of IND Application
14th Jan 202111:50 amRNSAesthetic Med & Dermatology Veterans Join Follica
12th Jan 202111:50 amRNSVedanta Receives $25M Investment from Pfizer Inc
5th Jan 20217:00 amRNSPRTC Appoints Biotech Analyst & Senior Exec as CFO
4th Jan 20217:00 amRNSTotal Voting Rights
21st Dec 202012:00 pmRNSPureTech to Present at JPM and Other Conferences
21st Dec 20207:00 amRNSDirector/PDMR Shareholding
11th Dec 202012:00 pmRNSPRTC Starts LYT-200 Clinical Trial in Solid Tumors
11th Dec 20207:00 amRNSHolding(s) in Company
10th Dec 202012:00 pmRNSLYT-100 Advances to Phase 2a Study in Lymphedema
9th Dec 202012:00 pmRNSFollica Female Hair Loss Academic Study Published
3rd Dec 202012:00 pmRNSPureTech Initiates Ph 2 of LYT-100 in Long COVID
1st Dec 20207:00 amRNSTotal Voting Rights
30th Nov 202012:00 pmRNSPureTech to Host Virtual R&D Day for Investors
27th Nov 20204:41 pmRNSSecond Price Monitoring Extn
27th Nov 20204:37 pmRNSPrice Monitoring Extension
27th Nov 20207:05 amRNSPDMR DEALING - PURCHASE OF SHARES

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.